iBio, Inc. (IBIO)
NYSEAMERICAN: IBIO · Real-Time Price · USD
2.480
+0.060 (2.48%)
At close: Dec 20, 2024, 4:00 PM
2.310
-0.170 (-6.85%)
After-hours: Dec 20, 2024, 7:58 PM EST
iBio, Inc. Employees
iBio, Inc. had 16 employees as of June 30, 2024. The number of employees decreased by 10 or -38.46% compared to the previous year.
Employees
16
Change (1Y)
-10
Growth (1Y)
-38.46%
Revenue / Employee
$10,938
Profits / Employee
-$1,446,875
Market Cap
22.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Allurion Technologies | 504 |
Co-Diagnostics | 155 |
Vivos Therapeutics | 123 |
Pulmatrix | 22 |
NeurAxis | 19 |
GeoVax Labs | 17 |
NeuroOne Medical Technologies | 16 |
NanoViricides | 7 |
IBIO News
- 5 weeks ago - iBio Reports Fiscal First Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - iBio Reports Fiscal Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - iBio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business Development - GlobeNewsWire
- 7 months ago - iBio Closes Sale of Manufacturing Facility in Texas - GlobeNewsWire
- 7 months ago - iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 9 months ago - iBio stock nearly tripled on Wednesday: here's why - Invezz
- 9 months ago - iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases - GlobeNewsWire